Home > Resources > Whitepapers > The Year in CRISPRs

The Year in CRISPRs

December 17, 2017

The news was full of CRISPR developments in 2015. New insights into the structures and mechanisms of CRISPR systems were reported. New tools and techniques were introduced. And new applications were explored. The newest CRISPR developments usually appear in peer-reviewed studies that emphasize incremental improvements. These studies tend to be highly focused and technically oriented, and hence fairly narrow. Taken as a whole, however, CRISPR studies form a broad and steadily advancing front, as this ebook demonstrates.

Spotlight

GroCell-3D™ Scaffolds

GroCell-3D™ Scaffold is a highly porous, organic matrix, providing an animal-free, innovative 3D environment for cell growth, interaction, and differentiation.

OTHER WHITEPAPERS

Becoming a life sciences superpower

whitePaper | September 1, 2021

This report advocates for increased, long-term public investment in research and innovation, particularly in the life sciences sector, to accelerate the UK on its trajectory as a global leader in the field. This report sets out recommendations ahead of the Comprehensive Spending Review for policymakers to support innovative businesses, achieve the Prime Minister’s aim of becoming a life sciences superpower, and ultimately, deliver health benefits for Britain – and the world – for generations to come.

Viral Vectors as a Gene Delivery Vehicle

whitePaper | August 5, 2022

The field of gene and cell therapy is experiencing a renaissance, with innovations in the use of viral vectors as a gene delivery vehicle being a key factor in the field’s growth.

Multi-Attribute Methods for Biopharmaceutical Analysis

whitePaper | December 5, 2022

The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years.

Cell and Gene Therapy Hot Buttons Series

whitePaper | September 27, 2022

Cell and Gene Therapy (CAGT) activity has increased dramatically in recent decades, especially in Chimeric Antigen Receptor T-Cell (CAR-T) clinical trials and therapy registrations. The IQVIA CAGT Hot Buttons series covers basic concepts in CAGT for newcomers to this field.

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

More Whitepapers